Tina Duong talks through the findings of a real-world follow-up study demonstrating that treatment with nusinersen is associated with continued stabilization of motor function over 2–3 years among adult patients with spinal muscular atrophy (3:08).
Tina Duong talks through the findings of a real-world follow-up study demonstrating that treatment with nusinersen is associated with continued stabilization of motor function over 2–3 years among adult patients with spinal muscular atrophy (3:08).
Don’t fall behind!
Get the latest headlines – in your specialties of choice – delivered straight to your inbox.
medwireNews Deputy Bureau Chief
© 2023 Springer Healthcare Limited.
Part of the Springer Nature Group.
